Alan B. Sandler - 20 Mar 2026 Form 3 Insider Report for Revolution Medicines, Inc. (RVMD)

Reporting relationship: Chief Development Officer
Issuer ticker: RVMD
Reported as of: 20 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 26 Mar 2026, 18:35:03 UTC
Prior SEC filing: 21 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Jack Anders, as Attorney-in-fact for Alan Sandler

Key filing fact

Alan B. Sandler filed Form 3 for Revolution Medicines, Inc. (RVMD) on 26 Mar 2026.

Key facts

This page summarizes Alan B. Sandler's Form 3 filing for Revolution Medicines, Inc. (RVMD).
0 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 26 Mar 2026, 18:35.

Change

Previous filing in this sequence was filed on 21 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001835966 Primary reporting owner

Sandler Alan B.

Relationship: Chief Development Officer
Address: C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY
Signature: /s/ Jack Anders, as Attorney-in-fact for Alan Sandler
Signature date: 26 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RVMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 53,000
Date: 20 Mar 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RVMD holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 20 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 167,300
Exercise price: $58.84
Footnotes: F2

RVMD holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 20 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,700
Exercise price: $102.02
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Includes 53,000 Restricted Stock Units.

Footnote F2

Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from November 1, 2025 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Footnote F3

One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2026 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

SEC remarks

Exhibit 24 - Power of Attorney